Functional Proteomics Laboratory, Centro Nacional de Biotecnología - CSIC, Proteored-ISCIII, 28049 Madrid, Spain.
National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), 28029 Madrid, Spain; Program of Hepatology, Center for Applied Medical Research (CIMA), University of Navarra, 31008 Pamplona, Spain.
J Proteomics. 2021 Jan 6;230:103984. doi: 10.1016/j.jprot.2020.103984. Epub 2020 Sep 12.
The analysis of biological fluids to identify proteins that may indicate a disease setting, state and progression, is an increasingly explored field. Despite the expectatives created, there are several hurdles that must be solved to reach an extensive proteome coverage using mass spectrometry, mainly due to the complex composition of the matrices. In this regard, bile is specially challenging and yet, very attractive, as a proximal fluid that might provide valuable information for the management of liver and pancreas associated diseases. Proteins account for less than 5% of bile organic components and, although optimized protocols for protein extraction have been developed, only partial descriptions of bile proteome have been achieved. In this manuscript a new procedure is described that significantly improves protein recovery from rat bile, which reduces by a factor of six the sample amount required for a typical proteomics analysis. Moreover, the number of proteins reliably identified in a single nanoLC-MS/MS run from 1 μg protein was increased by three-fold. This procedure provides a valuable resource to dig deeper into the molecular composition of bile and open new avenues to identify new hallmarks of disease such as cholangiocarcinoma, hepatocellular carcinoma and pancreatic cancer for their better clinical management.
分析生物体液中的蛋白质,以鉴定可能表明疾病状态、进程的蛋白质,是一个日益受到探索的领域。尽管人们对此寄予厚望,但要使用质谱法实现广泛的蛋白质组覆盖,仍有几个障碍需要解决,主要是由于基质的复杂组成。在这方面,胆汁特别具有挑战性,但也非常有吸引力,因为它是一种近端体液,可能为肝脏和胰腺相关疾病的治疗提供有价值的信息。蛋白质在胆汁的有机成分中占比不到 5%,尽管已经开发出了用于蛋白质提取的优化方案,但仅对胆汁蛋白质组进行了部分描述。本文描述了一种新的程序,可显著提高从大鼠胆汁中回收蛋白质的效率,这将减少典型蛋白质组学分析所需的样本量六倍。此外,还将单次纳升液相色谱-串联质谱(nanoLC-MS/MS)运行中可靠鉴定的蛋白质数量增加了三倍。该程序为深入研究胆汁的分子组成提供了有价值的资源,并为鉴定胆管癌、肝细胞癌和胰腺癌等疾病的新特征开辟了新途径,以更好地进行临床管理。